The George Institute For Global Health
Global
United Kingdom
India
China
Australia

Media releases

Media release: 
12/12/2018

A new trial could transform the treatment of chronic kidney disease (CKD) and could benefit thousands of people in Australia.

Media release: 
12/12/2018

The George Institute for Global Health was awarded almost $12 million from the NHMRC today for research that will improve the lives of people with chronic kidney disease, septic shock and chronic obstructive pulmonary disorder (COPD)

Media release: 
03/12/2018

High profile brands could see their Health Star Rating (HSR) slashed as part of a review to make sure the system works for Australians, not just food companies.

Media release: 
29/11/2018

The Honourable Ken Wyatt AM, MP, Minister for Senior Australians and Aged Care, Minister for Indigenous Health, spoke at The George Institute’s latest #GeorgeTalks Q and A event, hosted at Parliament House, Canberra.

Media release: 
11/10/2018

Young adults classified as obese in Australia can expect to lose up to 10 years in life expectancy, according to a major new study.

Media release: 
17/09/2018

Australia’s health system is under strain and in urgent need of transformation to strengthen consumer-centred and community-based primary health services a new report has found.

Media release: 
10/09/2018

The number of people with sepsis in Australian intensive care units (ICUs) is 50% higher than previously reported. The report from Royal North Shore Hospital and The George Institute for Global Health also found death rates for sepsis had been underestimated by 10%, with around a third of patients with sepsis in ICUs losing their lives.

Media release: 
29/08/2018

The George Institute for Global Health has been ranked the top independent research organisation in Australia, and come in at 33rd overall in the world.

The review of the world’s non-university and non-commercial research organisations was produced for Times Higher Education and is based on field-weighted citation impact (FWCI).

Media release: 
15/08/2018

A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world. 

A trial led by The George Institute for Global Health revealed that most patients – 70 per cent – reached blood pressure targets with the ‘Triple Pill’, compared to just over half receiving normal care.

Pages